Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
ANUH PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ANUH PHARMA Mar-23 |
TEVA PHARMA Dec-13 |
ANUH PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 110 | 3,483 | - | |
Low | Rs | 77 | 3,026 | - | |
Sales per share (Unadj.) | Rs | 105.3 | 1,998.8 | - | |
Earnings per share (Unadj.) | Rs | 7.2 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | 9.2 | 286.4 | - | |
Dividends per share (Unadj.) | Rs | 2.00 | 109.31 | - | |
Avg Dividend yield | % | 2.1 | 3.4 | 63.7% | |
Book value per share (Unadj.) | Rs | 48.1 | 2,220.3 | - | |
Shares outstanding (eoy) | m | 50.11 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.9 | 1.6 | 54.5% | |
Avg P/E ratio | x | 12.9 | 26.1 | 49.7% | |
P/CF ratio (eoy) | x | 10.2 | 11.4 | 89.8% | |
Price / Book Value ratio | x | 1.9 | 1.5 | 132.5% | |
Dividend payout | % | 27.7 | 87.5 | 31.6% | |
Avg Mkt Cap | Rs m | 4,683 | 2,759,528 | 0.2% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 172 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,712.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,355.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 5,275 | 1,695,000 | 0.3% | |
Other income | Rs m | 61 | 0 | - | |
Total revenues | Rs m | 5,336 | 1,695,000 | 0.3% | |
Gross profit | Rs m | 518 | 464,177 | 0.1% | |
Depreciation | Rs m | 97 | 137,008 | 0.1% | |
Interest | Rs m | 7 | 33,293 | 0.0% | |
Profit before tax | Rs m | 475 | 293,876 | 0.2% | |
Minority Interest | Rs m | 0 | 1,335 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,913 | -0.0% | |
Tax | Rs m | 113 | -3,588 | -3.1% | |
Profit after tax | Rs m | 362 | 105,885 | 0.3% | |
Gross profit margin | % | 9.8 | 27.4 | 35.9% | |
Effective tax rate | % | 23.8 | -1.2 | -1,948.2% | |
Net profit margin | % | 6.9 | 6.2 | 109.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3,076 | 1,144,797 | 0.3% | |
Current liabilities | Rs m | 1,613 | 998,360 | 0.2% | |
Net working cap to sales | % | 27.7 | 8.6 | 321.0% | |
Current ratio | x | 1.9 | 1.1 | 166.3% | |
Inventory Days | Days | 66 | 91 | 72.4% | |
Debtors Days | Days | 1,185 | 96 | 1,235.3% | |
Net fixed assets | Rs m | 966 | 553,624 | 0.2% | |
Share capital | Rs m | 251 | 4,172 | 6.0% | |
Net worth | Rs m | 2,412 | 1,882,824 | 0.1% | |
Long term debt | Rs m | 0 | 866,691 | 0.0% | |
Total assets | Rs m | 4,042 | 3,873,619 | 0.1% | |
Interest coverage | x | 64.6 | 9.8 | 657.7% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.3 | 0.4 | 298.2% | |
Return on assets | % | 9.1 | 3.6 | 254.3% | |
Return on equity | % | 15.0 | 5.6 | 266.7% | |
Return on capital | % | 20.0 | 4.9 | 405.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 539 | 270,095 | 0.2% | |
From Investments | Rs m | -435 | -95,706 | 0.5% | |
From Financial Activity | Rs m | -123 | -323,998 | 0.0% | |
Net Cashflow | Rs m | -19 | -149,608 | 0.0% |
Compare ANUH PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare ANUH PHARMA With: AAREY DRUGS UNJHA FORMUL SAKAR HEALTHCARE AARTI DRUGS CIAN HEALTHCARE
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.